14-day Premium Trial Subscription Try For FreeTry Free

Concert Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -36.21. In total, the insiders bought 0 and sold 4 463 235 CNCE shares in the last 100 trades.

Insider Power

(Last 100 transactions)
-36.21
Buy 0 Shares
Sell 4 463 235 Shares

Historical Insider Trades

Date Type Action Person Amount
Mar 06, 2023 Common Stock Sell Van Heek Christi 25 651
Mar 06, 2023 Common Stock Sell Van Heek Christi 16 400
Mar 06, 2023 Stock Option (Right to Buy) Sell Van Heek Christi 25 000
Mar 06, 2023 Stock Option (Right to Buy) Sell Van Heek Christi 10 000
Mar 06, 2023 Stock Option (Right to Buy) Sell Van Heek Christi 10 000
Mar 06, 2023 Stock Option (Right to Buy) Sell Van Heek Christi 10 000
Mar 06, 2023 Stock Option (Right to Buy) Sell Van Heek Christi 14 144
Mar 06, 2023 Stock Option (Right to Buy) Sell Van Heek Christi 10 250
Mar 06, 2023 Stock Option (Right to Buy) Sell Van Heek Christi 7 003
Mar 06, 2023 Common Stock Sell Tung Roger D 12 389
Mar 06, 2023 Common Stock Sell Tung Roger D 57 916
Mar 06, 2023 Performance Stock Units Sell Tung Roger D 156 675
Mar 06, 2023 Stock Option (Right to Buy) Sell Tung Roger D 203 300
Mar 06, 2023 Stock Option (Right to Buy) Sell Tung Roger D 170 000
Mar 06, 2023 Stock Option (Right to Buy) Sell Tung Roger D 200 000
Mar 06, 2023 Stock Option (Right to Buy) Sell Tung Roger D 200 000
Mar 06, 2023 Stock Option (Right to Buy) Sell Tung Roger D 200 000
Mar 06, 2023 Stock Option (Right to Buy) Sell Tung Roger D 151 600
Mar 06, 2023 Stock Option (Right to Buy) Sell Tung Roger D 205 000
Mar 06, 2023 Common Stock Sell Stuart Nancy 167 963
Mar 06, 2023 Common Stock Sell Stuart Nancy 73 233
Mar 06, 2023 Performance Stock Units Sell Stuart Nancy 21 400
Mar 06, 2023 Stock Option (Right to Buy) Sell Stuart Nancy 100 000
Mar 06, 2023 Stock Option (Right to Buy) Sell Stuart Nancy 80 000
Mar 06, 2023 Stock Option (Right to Buy) Sell Stuart Nancy 70 000
Click to get the best stock tips daily for free!

About Concert Pharmaceuticals

Concert Pharmaceuticals Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has strategic collaborations with Avanir Pharmaceuticals, Inc.; Jazz Pharmaceuticals, Inc.; Cipla Technologi... CNCE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT